Table 2 Serum adrenal hormones, endothelial, and inflammatory markers in control, obese patients with NT, pre-HT & HT

9.1 ± 1.4

5.6 ± 0.7*

8.9 ± 2.4*^{, #}

12.7 ± 0.5*^{, #, a}

88.6 ± 8.5

132.1 ± 6.9*

195.9 ± 70.9*^{, #}

320.2 ± 22.4*^{,#, a}

23.8 ± 2.9

24.8 ± 5.6

79.6 ± 42.07*^{, #}

44.2 ± 7.5*^{, #, a}

73.07 ± 11.05

377.3 ± 87.8*

585.7 ± 155.7*^{, #}

881.1 ± 130.9*^{, # a}

2.3 ± 0.5

6.02 ± 1.4*

14.3 ± 7.6*^{, #}

31.6 ± 6.7*^{, #, a}

1.2 ± 0.2

5.1 ± 1.2*

9.3 ± 4.6*^{, #}

18.5 ± 2.4*^{, #, a}

16.1 ± 3.1

76.9 ± 6.3*

93.5 ± 15.5*^{, #}

186.6 ± 23.5*^{, #, a}

0.3 ± 0.09

0.9 ± 0.12*

1.8 ± 0.9*^{, #}

3.7 ± 0.8*^{, #, a}